Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Blood|October 29, 2015
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cellsLaurie Menger, Agnes Gouble, Maria A V Marzolini, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Nature Immunology|September 6, 2011
Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1Sungchul Kim, Sanghyun Lee, Jinwook Shin, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Analysis of ROR1 Protein Expression in Human Cancer and Normal TissuesAshwini Balakrishnan, Tracy Goodpaster, Julie Randolph-Habecker, et al.
Journal for Immunotherapy of Cancer|April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapyBrett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Plos One|December 21, 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaLihua E Budde, Carolina Berger, Yukang Lin, et al.
Science (New York, N.Y.)|September 9, 2006
An antigen produced by splicing of noncontiguous peptides in the reverse orderEdus H Warren, Nathalie J Vigneron, Marc A Gavin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture ConditionsSang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Blood Advances|December 5, 2022
Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor functionIsabel Leung, Megan L Templeton, Yun Lo, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Blood|October 29, 2015
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cellsLaurie Menger, Agnes Gouble, Maria A V Marzolini, et al.
British Journal of Haematology|November 18, 2003
Disparity for a newly identified minor histocompatibility antigen, HA-8, correlates with acute graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical siblingYoshiki Akatsuka, Edus H Warren, Ted A Gooley, et al.
Nature Immunology|September 6, 2011
Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1Sungchul Kim, Sanghyun Lee, Jinwook Shin, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Analysis of ROR1 Protein Expression in Human Cancer and Normal TissuesAshwini Balakrishnan, Tracy Goodpaster, Julie Randolph-Habecker, et al.
Journal for Immunotherapy of Cancer|April 10, 2020
Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapyBrett A Schroeder, Ralph Graeme Black, Sydney Spadinger, et al.
Plos One|December 21, 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaLihua E Budde, Carolina Berger, Yukang Lin, et al.
Science (New York, N.Y.)|September 9, 2006
An antigen produced by splicing of noncontiguous peptides in the reverse orderEdus H Warren, Nathalie J Vigneron, Marc A Gavin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture ConditionsSang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Blood Advances|December 5, 2022
Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor functionIsabel Leung, Megan L Templeton, Yun Lo, et al.
Pageof 18